NOVA2 expression in pituitary gland and in functioning and non-functioning pituitary adenomas: a preliminary study

Area of Science:

• Endocrinology
• Oncology
• Molecular Biology

Background:

• Pituitary adenomas (PAs) are common tumors with limited treatment options, especially non-functioning PAs (NFPAs).
• Current therapies for PAs show limited efficacy, necessitating novel diagnostic and therapeutic targets.
• Neuro-Oncological Ventral Antigen 2 (NOVA2) is a key regulator of alternative splicing.

Purpose of the Study:

• To investigate the expression of NOVA2 in normal pituitary glands and PAs.
• To evaluate NOVA2 as a potential diagnostic and therapeutic target for PAs.

Main Methods:

• Immunohistochemical analysis of NOVA2 expression in 12 PA samples (9 NFPAs, 3 FPAs) and 8 normal pituitary glands.
• Semi-quantitative evaluation using Histoscore to assess NOVA2 staining intensity.

Main Results:

• NOVA2 was detected in endothelial cells of both PAs and normal pituitary glands, with higher expression in PAs.
• NOVA2 was present in PA cells irrespective of adenoma type (functioning or non-functioning).
• Normal pituitary epithelial cells were negative for NOVA2 expression.

Conclusions:

• This study is the first to report NOVA2 expression in PA cells but not in normal pituitary epithelial cells.
• NOVA2 represents a promising novel target for diagnostic and therapeutic strategies in pituitary adenomas.
• Further studies with larger cohorts are needed to validate these preliminary findings.